Healthcare Global Enterprises
Healthcare Global Enterprises Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Healthcare Global Enterprises
Start SIPHealthcare Global Enterprises F&O
Healthcare Global Enterprises Investment Rating
-
Master Rating:
-
Healthcare Global Ents. has an operating revenue of Rs. 1,617.36 Cr. on a trailing 12-month basis. An annual revenue growth of 37% is outstanding, Pre-tax margin of 6% is okay, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 42%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 36 which is a POOR score indicating inconsistency in earnings, a RS Rating of 44 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 43 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 253 | 253 | 243 | 220 |
| Operating Expenses Qtr Cr | 203 | 206 | 197 | 180 |
| Operating Profit Qtr Cr | 50 | 47 | 46 | 40 |
| Depreciation Qtr Cr | 22 | 22 | 22 | 22 |
| Interest Qtr Cr | 11 | 12 | 10 | 9 |
| Tax Qtr Cr | 5 | 3 | 6 | 2 |
| Net Profit Qtr Cr | 14 | 11 | 11 | -18 |
Healthcare Global Enterprises Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 2
- Bearish Moving Average
- ___
- 14
- 20 Day
- 269.71
- 50 Day
- 276.56
- 100 Day
- 280.86
- 200 Day
- 278.62
- 20 Day
- 271.38
- 50 Day
- 278.34
- 100 Day
- 287.1
- 200 Day
- 283.09
Healthcare Global Enterprises Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 265.89 |
| Second Resistance | 270.12 |
| Third Resistance | 272.64 |
| RSI | 38.66 |
| MFI | 31.1 |
| MACD Single Line | -4.09 |
| MACD | -4.78 |
| Support | |
|---|---|
| First Resistance | 259.14 |
| Second Resistance | 256.62 |
| Third Resistance | 252.39 |
Healthcare Global Enterprises Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 73,278 | 4,902,298 | 66.9 |
| Week | 105,206 | 6,119,845 | 58.17 |
| 1 Month | 133,576 | 10,353,487 | 77.51 |
| 6 Month | 154,392 | 9,640,209 | 62.44 |
Healthcare Global Enterprises Result Highlights
Healthcare Global Enterprises Synopsis
NSE-Medical-Hospitals
Healthcare Global En is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 851.96 Cr. and Equity Capital is Rs. 139.01 Cr. for the Year ended 31/03/2022. Healthcare Global Enterprises Ltd. is a Public Limited Listed company incorporated on 12/03/1998 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L15200KA1998PLC023489 and registration number is 023489.| Market Cap | 3,667 |
| Sales | 969 |
| Shares in Float | 4.03 |
| No of funds | 60 |
| Yield |
| Book Value | 3.34 |
| U/D Vol ratio | 0.9 |
| LTDebt / Equity | 7 |
| Alpha | -0.01 |
| Beta | 0.53 |
Healthcare Global Enterprises
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 71.38% | 71.39% | 71.42% | |
| Mutual Funds | 3.01% | 2.81% | 2.94% | |
| Insurance Companies | 0.4% | 0.62% | ||
| Foreign Portfolio Investors | 7.18% | 7.27% | 7.22% | |
| Financial Institutions/ Banks | 0.62% | |||
| Individual Investors | 11.6% | 11.21% | 11.58% | |
| Others | 6.43% | 6.7% | 6.22% |
Healthcare Global Enterprises Management
| Name | Designation |
|---|---|
| Dr. B S Ajai Kumar | Executive Chairman |
| Ms. Anjali Ajaikumar Rossi | Executive Director |
| Mr. Shanker Annaswamy | Independent Director |
| Mr. Abhay Prabhakar Havaldar | Non Exe. & Ind. Director |
| Ms. Geeta Mathur | Non Exe. & Ind. Director |
| Mr. Rajagopalan Raghavan | Non Exe. & Ind. Director |
| Mr. Siddharth Patel | Non Exe.Non Ind.Director |
| Mr. Amit Soni | Non Exe.Non Ind.Director |
| Mr. Meghraj Arvindrao Gore | WholeTime Director & CEO |
| Mr. Jeyandran Venugopal | Non Exe. & Ind. Director |
| Mr. Pradip Kanakia | Non Exe. & Ind. Director |
Healthcare Global Enterprises Forecast
Price Estimates
Healthcare Global Enterprises FAQs
What is Share Price of Healthcare Global Enterprises ?
Healthcare Global Enterprises share price is ₹264 As on 26 March, 2023 | 21:23
What is the Market Cap of Healthcare Global Enterprises ?
The Market Cap of Healthcare Global Enterprises is ₹3672.7 Cr As on 26 March, 2023 | 21:23
What is the P/E ratio of Healthcare Global Enterprises ?
The P/E ratio of Healthcare Global Enterprises is 136.2 As on 26 March, 2023 | 21:23
What is the PB ratio of Healthcare Global Enterprises ?
The PB ratio of Healthcare Global Enterprises is 4.2 As on 26 March, 2023 | 21:23